{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Autotransfusion", "COVID-19", "Cytokine release syndrome (CRS)", "Lipid ozonation products", "Medical O3", "O3 gas", "O3 therapy", "Oxidative stress", "Reactive oxidative species", "SARS-CoV-2"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33131033", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "22"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "17"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "11", "Day": "01"}], "ELocationID": ["10.1007/s11739-020-02542-6"], "Journal": {"ISSN": "1970-9366", "JournalIssue": {"Volume": "16", "Issue": "3", "PubDate": {"Year": "2021", "Month": "Apr"}}, "Title": "Internal and emergency medicine", "ISOAbbreviation": "Intern Emerg Med"}, "ArticleTitle": "Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.", "Pagination": {"StartPage": "669", "EndPage": "675", "MedlinePgn": "669-675"}, "Abstract": {"AbstractText": ["The emerging outbreak of the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide. We prescribed some promising medication to our patients with mild to moderate pneumonia due to SARS-CoV-2, however such drugs as chloroquine, hydrossichloroquine, azithromycin, antivirals (lopinavir/ritonavir, darunavir/cobicistat) and immunomodulating agents (steroids, tocilizumab) were not confirmed as effective against SARS-CoV2. We, therefore, started to use auto-hemotherapy treated with an oxygen/ozone (O<sub>2</sub>/O<sub>3</sub>) gaseous mixture as adjuvant therapy. In Udine University Hospital (Italy) we performed a case-control study involving hospitalized adult patients with confirmed COVID-19 with mild to moderate pneumonia. Clinical presentations are based upon clinical phenotypes identified by the Italian Society of Emergency and Urgency Medicine (SIMEU-Societ\u00e0 Italiana di Medicina di Emergenza-Urgenza) and patients that met criteria of phenotypes 2 to 4 were treated with best available therapy (BAT), with or without O<sub>3</sub>-autohemotherapy. 60 patients were enrolled in the study: 30 patients treated with BAT and O<sub>2</sub>/O<sub>3</sub> mixture, as adjuvant therapy and 30 controls treated with BAT only. In the group treated with O<sub>3</sub>-autohemotherapy plus BAT, patients were younger but with more severe clinical phenotypes. A decrease of SIMEU clinical phenotypes was observed (2.70\u2009\u00b1\u20090.67 vs. 2.35\u2009\u00b1\u20090.88, p\u2009=\u20090.002) in all patients during hospitalization but this clinical improvement\u00a0was statistically significant only in O<sub>3</sub>-treated patients (2.87\u2009\u00b1\u20090.78 vs. 2.27\u2009\u00b1\u20090.83, p\u2009<\u20090.001), differently to the control group (2.53\u2009\u00b1\u20090.51 vs. 2.43\u2009\u00b1\u20090.93, p\u2009=\u20090.522). No adverse events were observed associated with the application of O<sub>2</sub>/O<sub>3</sub> gaseous mixture. O<sub>2</sub>/O<sub>3</sub> therapy as adjuvant therapy could be useful in mild to moderate pneumonia due to SARS-CoV-2. Randomized prospective study is ongoing [Clinical Trials.gov ID: Z7C2CA5837]."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy. c.tascini@gmail.com."}], "LastName": "Tascini", "ForeName": "Carlo", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SOC Anestesia e Rianimazione Uno, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "Sermann", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "Pagotto", "ForeName": "Alberto", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}, {"Identifier": [], "Affiliation": "Pronto Soccorso e Medicina d'urgenza / HDU Livorno, Azienda USL, Toscana Nord Ovest, 33100, Livorno, Italy."}], "LastName": "Sozio", "ForeName": "Emanuela", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "De Carlo", "ForeName": "Chiara", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "Giacinta", "ForeName": "Alessandro", "Initials": "A"}, {"Identifier": ["0000-0003-4607-0373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Lipoapheresis and Center for Inherited Dyslipidemias, Fondazione Toscana \"Gabriele Monasterio\", Via Moruzzi, 1, 56124, Pisa, Italy. francesco.sbrana@ftgm.it."}], "LastName": "Sbrana", "ForeName": "Francesco", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Deep Health Unit, Fondazione Toscana \"Gabriele Monasterio\", Via Moruzzi, 1, 56124, Pisa, Italy."}], "LastName": "Ripoli", "ForeName": "Andrea", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "Castaldo", "ForeName": "Nadia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "Merelli", "ForeName": "Maria", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "U.O. Malattie Infettive, Dipartimento di Medicina dell'Universit\u00e0 di Udine, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "Cadeo", "ForeName": "Barbara", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SOC Anestesia e Rianimazione Uno, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "Macor", "ForeName": "Cristiana", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SOC Anestesia e Rianimazione Uno, Universit\u00e0 di Udine e Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330, 33100, Udine, Italy."}], "LastName": "De Monte", "ForeName": "Amato", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Intern Emerg Med", "NlmUniqueID": "101263418", "ISSNLinking": "1828-0447"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "CommentsCorrectionsList": [{"RefSource": "Intern Emerg Med. 2021 Apr;16(3):793-794. doi: 10.1007/s11739-020-02592-w", "PMID": "33400161"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["blood", "therapy"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Case-Control Studies"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Italy"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Phenotype"}, {"QualifierName": ["blood", "therapy", "virology"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "C.T. has received funds for speaking at symposia organized on behalf of Pfizer, Novartis, Merck, Angelini, Zambon, Thermofischer, Biotest, Gilead, Hikma, Biomerieux and Astellas. All other authors: None."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "World Health Organization. Situation updates on July 20 2020. https://www.who.int/emergiencies/disease/novel-coronavirus-2019/situation-reports/. Accessed 20 July 2020"}, {"Citation": "Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001282.", "ArticleIdList": ["10.1056/NEJMoa2001282", "PMC7121492", "32187464"]}, {"Citation": "Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105954.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105954", "PMC7118634", "32234467"]}, {"Citation": "Lu CC, Chen MY, Chang YL. Potential therapeutic agents against COVID-19: what we know so far. J Chin Med Assoc. 2020 doi: 10.1097/JCMA.0000000000000318.", "ArticleIdList": ["10.1097/JCMA.0000000000000318", "PMC7176266", "32243270"]}, {"Citation": "Fanin A, Calegari J, Beverina A, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19. Intern Emerg Med. 2020;15:841\u2013843. doi: 10.1007/s11739-020-02388-y.", "ArticleIdList": ["10.1007/s11739-020-02388-y", "PMC7261210", "32474851"]}, {"Citation": "Elvis AM, Ekta JS. Ozone therapy: a clinical review. J Nat Sci Biol Med. 2011;2:66\u201370. doi: 10.4103/0976-9668.82319.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Bocci AV. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37:425\u2013435. doi: 10.1016/j.arcmed.2005.08.006.", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Bocci AV, Zanardi I, Travagli V. Ozone acting on human blood yelds a hormetic dose-resposne relationship. J Transl Med. 2011;9:66. doi: 10.1186/1479-5876-9-66.", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Rowen RJ. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med Gas Res. 2019;9:232\u2013237.", "ArticleIdList": ["PMC7802416", "31898609"]}, {"Citation": "Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7(3):212\u2013219. doi: 10.4103/2045-9912.215752.", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Gulmen S, Kurtoglu T, Meteoglu I, Kaya S, Okutan H. Ozone therapy as an adjunct to vancomycin enhances bacterial elimination in methicillin resistant Staphylococcus aureus mediastinitis. J Surg Res. 2013;185:64\u201369. doi: 10.1016/j.jss.2013.05.085.", "ArticleIdList": ["10.1016/j.jss.2013.05.085", "23809152"]}, {"Citation": "Caliskan B, Guven A, Ozler M, Cayci T, Ozcan A, Bedir O, Surer I, Korkmaz A. Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis. Scand J Clin Lab Invest. 2011;71:473\u2013480. doi: 10.3109/00365513.2011.587022.", "ArticleIdList": ["10.3109/00365513.2011.587022", "21923232"]}, {"Citation": "Ricevuti G, Franzini M, Valdenassi L. Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures. Ozone Ther. 2020 doi: 10.4081/ozone.2020.9014.", "ArticleIdList": ["10.4081/ozone.2020.9014"]}, {"Citation": "https://www.simeu.it/w/articoli/leggiArticolo/3964/leggi"}, {"Citation": "R Core Team. R: a language and environment for statistical computing. Vienna, Austria. 2013. https://www.R-project.org/"}, {"Citation": "https://coronavirus.jhu.edu/data/mortality"}, {"Citation": "Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, COVID-19 Lombardy ICU Network Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 doi: 10.1001/jama.2020.5394.", "ArticleIdList": ["10.1001/jama.2020.5394", "PMC7136855", "32250385"]}, {"Citation": "Perlini S, Canevari F, Cortesi S, et al. Emergency department and out-of-hospital emergency system (112\u2014AREU 118) integrated response to Coronavirus disease 2019 in a Northern Italy centre. Intern Emerg Med. 2020;15:825\u2013833. doi: 10.1007/s11739-020-02390-4.", "ArticleIdList": ["10.1007/s11739-020-02390-4", "PMC7276336", "32507926"]}, {"Citation": "Erika P, Andrea V, Cillis MG, et al. Triage decision-making at the time of COVID-19 infection: the Piacenza strategy. Intern Emerg Med. 2020;15:879\u2013882. doi: 10.1007/s11739-020-02350-y.", "ArticleIdList": ["10.1007/s11739-020-02350-y", "PMC7210104", "32385627"]}, {"Citation": "Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020 doi: 10.1056/NEJMoa2007016.", "ArticleIdList": ["10.1056/NEJMoa2007016", "PMC7169476", "32275812"]}, {"Citation": "World Health Organization. Clinical management of COVID-19\u2014interim guidance. https://www.who.int/publications/i/item/clinical-management-of-covid-19"}, {"Citation": "Leon OS, Menendez S, Merino N, Castillo R, Sam S, Perez L, Cruz E, Bocci V. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm. 1998;7:289\u2013294. doi: 10.1080/09629359890983.", "ArticleIdList": ["10.1080/09629359890983", "PMC1781855", "9792340"]}, {"Citation": "Clavo B, Rodriguez-Esparragon F, Rodriguez-Abreu D, Martinez-Sanchez G, Llontop P, Aguiar-Bujanda D, Fernandez-Perez L, Santana-Rodriguez N. Modulation of oxidative stress by ozone therapy in the prevention and treatment of chemotherapy-induced toxicity: review and prospects. Antioxidants (Basel) 2019;8:588. doi: 10.3390/antiox8120588.", "ArticleIdList": ["10.3390/antiox8120588", "PMC6943601", "31779159"]}, {"Citation": "Rowen RJ, Robins H, Carew K, Kamara MM, Jalloh MI. Rapid resolution of haemorrhagic fever (Ebola) in Sierra Leone with ozone therapy. Afr J Infect Dis. 2016;10:49\u201354."}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "13"}, {"Year": "2020", "Month": "10", "Day": "14"}, {"Year": "2020", "Month": "11", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "1", "Hour": "20", "Minute": "43"}, {"Year": "2020", "Month": "11", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33131033", "PMC7603641", "10.1007/s11739-020-02542-6", "10.1007/s11739-020-02542-6"]}}], "PubmedBookArticle": []}